GREY:ATBPF - Post by User
Comment by
MrMugsyon Jan 17, 2021 10:38pm
302 Views
Post# 32317056
RE:RE:RE:Just reading about recent acquisition when suddenly..
RE:RE:RE:Just reading about recent acquisition when suddenly..Pragmatist wrote: MrMugsy wrote: A buyout would be great but regardless ... the value of ATE will eventually come through if you're a believer. Good companies always hit higher highs - it's just hard to call the dates when people get uber-excited.
ATE is suely creating options for OTENA and for their other drugs. Multiple pathways is the key to showing potential partners that ATE is in the driver's seat.
Also keep in mind that if ATE is likely already working with Big Pharma on COVID collaboration (as per Dan's inability to discuss the topic).
With any luck, the COVID work will help instill the value of these H2S patents and demonstrate first-hand how H2S may be valuable in blocking viral cell entry, inhibiting viral replication and/or supressing inflammation in the lungs.
I can wait for the excitement. Not the first time I have to wait for shareholders to figure it out. IMO.
That is a good thought, Mugsy.
It is common for suitors to start a relationship with a small biotech with a partnering/collaboration deal, and then acquire the company at a later stage of development. As one CEO put it, partnering is almost always the lead in to an acquisition.
Thank you. I was waiting for Dan to announce a collaboration (since the last letter to shareholders). Then finally realized ... COVID was probably the collaboration he was eluding to. Will see.